BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

483 related articles for article (PubMed ID: 26621911)

  • 1. Association of HIV, Hepatitis C Virus, and Liver Fibrosis Severity With the Enhanced Liver Fibrosis Score.
    Swanson S; Ma Y; Scherzer R; Huhn G; French AL; Plankey MW; Grunfeld C; Rosenberg WM; Peters MG; Tien PC
    J Infect Dis; 2016 Apr; 213(7):1079-86. PubMed ID: 26621911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of HIV infection, hepatitis C virus infection, and metabolic factors with liver stiffness measured by transient elastography.
    Bailony MR; Scherzer R; Huhn G; Plankey MW; Peters MG; Tien PC
    J Infect Dis; 2013 Dec; 208(11):1776-83. PubMed ID: 23901097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of Liver Fibrosis and Microbial Translocation to Immune Activation in Persons Infected With HIV and/or Hepatitis C Virus.
    Reid M; Ma Y; Scherzer R; Price JC; French AL; Huhn GD; Plankey MW; Peters M; Grunfeld C; Tien PC
    J Infect Dis; 2018 Mar; 217(8):1289-1297. PubMed ID: 29304196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver Fibrosis Evaluation Using Real-time Shear Wave Elastography in Hepatitis C-Monoinfected and Human Immunodeficiency Virus/Hepatitis C-Coinfected Patients.
    Verlinden W; Bourgeois S; Gigase P; Thienpont C; Vonghia L; Vanwolleghem T; Michielsen P; Francque S
    J Ultrasound Med; 2016 Jun; 35(6):1299-308. PubMed ID: 27151906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced liver fibrosis marker as a noninvasive predictor of mortality in HIV/hepatitis C virus-coinfected women from a multicenter study of women with or at risk for HIV.
    Peters MG; Bacchetti P; Boylan R; French AL; Tien PC; Plankey MW; Glesby MJ; Augenbraun M; Golub ET; Karim R; Parkes J; Rosenberg W
    AIDS; 2016 Mar; 30(5):723-9. PubMed ID: 26595542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
    Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
    Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
    Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
    HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.
    Hodowanec AC; Lee RD; Brady KE; Gao W; Kincaid S; Plants J; Bahk M; Mackman N; Landay AL; Huhn GD
    BMC Infect Dis; 2015 Apr; 15():190. PubMed ID: 25884329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.
    Price JC; Ma Y; Scherzer R; Korn N; Tillinghast K; Peters MG; Noworolski SM; Tien PC
    Hepatology; 2017 Mar; 65(3):853-863. PubMed ID: 27981599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preservation of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses despite global loss of CD4+ T cells in HCV/HIV coinfection.
    Morishima C; Shuhart MC; Yoshihara CS; Paschal DM; Silva MA; Thomassen LV; Emerson SS; Gretch DR
    J Infect Dis; 2007 Aug; 196(4):577-86. PubMed ID: 17624844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High Proportion of HIV-HCV Coinfected Patients with Advanced Liver Fibrosis Requiring Hepatitis C Treatment in Haiphong, Northern Vietnam (ANRS 12262).
    Nguyen Truong T; Laureillard D; Lacombe K; Duong Thi H; Pham Thi Hanh P; Truong Thi Xuan L; Chu Thi N; Luong Que A; Vu Hai V; Nagot N; Tuaillon E; Dominguez S; Lemoine M
    PLoS One; 2016; 11(5):e0153744. PubMed ID: 27148964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection.
    Bierhoff E; Fischer HP; Willsch E; Rockstroh J; Spengler U; Brackmann HH; Oldenburg J
    Virchows Arch; 1997 Apr; 430(4):271-7. PubMed ID: 9134037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels.
    Shah S; Ma Y; Scherzer R; Huhn G; French AL; Plankey M; Peters MG; Grunfeld C; Tien PC
    AIDS; 2015 Jul; 29(11):1325-33. PubMed ID: 25870985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis.
    Casado JL; Mena A; Bañón S; Castro A; Quereda C; Moreno A; Pedreira J; Moreno S
    HIV Med; 2016 Jan; 17(1):62-7. PubMed ID: 26122981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of extrinsic apoptosis pathway in HCV monoinfected and HIV-HCV coinfected patients, irrespective of liver disease severity.
    Feuth T; Van Baarle D; Hoepelman AI; Van Erpecum KJ; Siersema PD; Arends JE
    Apoptosis; 2014 Jul; 19(7):1128-35. PubMed ID: 24752774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infection.
    Sacchi P; Cima S; Corbella M; Comolli G; Chiesa A; Baldanti F; Klersy C; Novati S; Mulatto P; Mariconti M; Bazzocchi C; Puoti M; Pagani L; Filice G; Bruno R
    Dig Liver Dis; 2015 Mar; 47(3):218-25. PubMed ID: 25544657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marijuana Use Is Not Associated With Progression to Advanced Liver Fibrosis in HIV/Hepatitis C Virus-coinfected Women.
    Kelly EM; Dodge JL; Sarkar M; French AL; Tien PC; Glesby MJ; Golub ET; Augenbraun M; Plankey M; Peters MG
    Clin Infect Dis; 2016 Aug; 63(4):512-8. PubMed ID: 27225241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Enhanced Liver Fibrosis Index Predicts Hepatic Fibrosis Superior to FIB4 and APRI in HIV/HCV Infected Patients.
    Abdel-Hameed EA; Rouster SD; Kottilil S; Sherman KE
    Clin Infect Dis; 2021 Aug; 73(3):450-459. PubMed ID: 32459305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.
    Vidovic N; Lochowsky RS; Goldmann G; Rockstroh J; Wasmuth JC; Spengler U; Sauerbruch T; Lammert F; Oldenburg J; Grünhage F
    Haemophilia; 2010 Sep; 16(5):778-85. PubMed ID: 20331759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Bone Deficits in HIV/HCV-Coinfected, HCV-Monoinfected, and HIV-Monoinfected Women.
    Lo Re V; Lynn K; Stumm ER; Long J; Nezamzadeh MS; Baker JF; Hoofnagle AN; Kapalko AJ; Mounzer K; Zemel BS; Tebas P; Kostman JR; Leonard MB
    J Infect Dis; 2015 Sep; 212(6):924-33. PubMed ID: 25754980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.